Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery

Obesity

Volumn 21, Issue 6, 2013, Pages 1143-1147

  De Weijer, B A ^a   Aarts, E ^b   Janssen, I M C ^b   Berends, F J ^b   Van De Laar, A ^c   Kaasjager, K ^b   Ackermans, M T ^a   Fliers, E ^a   Serlie, M J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN SENSITIVITY; LIPID HYDROLYSIS; LIPOLYSIS; LIVER METABOLISM; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREMENOPAUSE; ROUX EN Y GASTRIC BYPASS SURGERY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TISSUE DISTRIBUTION; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 84881332568     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20220     Document Type: Article

References (26)

1. Sjöström L, Lindroos A, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
2. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
3. Rubino F,. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006; 9: 497-507.
4. Roberts CK, Barnard RJ,. Effects of exercise and diet on chronic disease. J Appl Physiol 2005; 98: 3-30.
5. Falkén Y, Hellström PM, Holst JJ, Näslund E,. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. Endocr Res 2011; 96: 2227-2235.
6. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14: 15-23.
7. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
8. Guidone C, Manco M, Valera-Mora E, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006; 49: 2136-2143.
9. 2O are higher than those measured with [2-13C]glycerol. J Clin Endocrinol Metab 2001; 86: 2220-2226.
10. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S,. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J lipid Res 2002; 432: 223-233.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Steele R,. Influences on glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959; 82: 420-430.
13. Finegood DT, Bergman RN, Vranic M,. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 1987; 36: 914-924.
14. Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R, Yki-Jarvinen H,. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 2007; 293: E1709-E1715.
15. Frayn KN,. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983; 55: 628-634.
16. Koutsari C, Jensen MD,. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 36: 981-989.
17. Lima MM, Pareja JC, Alegre SM, et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic- hyperinsulinemic clamp. Clin Endocrinol Metab 2010; 95: 3871-3875.
18. Ferrannini E, Mingrone G,. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009; 32: 514-520.
19. Salinari S, Bertuzzi A, Iaconelli A, Manco M, Mingrone G,. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia 2008; 51: 1276-1284.
20. Jazet I, Pijl H, Frölich M, Romijn J, Meinders A,. Two days of a very low caloric diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism 2005; 54: 705-712.
21. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325: 201-204.
22. Markovic TP, Campbell LV, Balasubramanian S, et al. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Diabetes Care 1998; 215: 695-700.
23. Bergman R, Ader M,. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000; 9: 351-356.
24. Johansson L, Roos M, Kullberg J, et al. Lipid mobilization following Roux-en-Y Gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg 2008; 218: 1297-1304.
25. Jocken JW, Moro C, Goossens GH, et al. Skeletal muscle lipase content and activity in obesity and type 2 diabetes. J Clin Endocrinol Metab 2010; 9: 5449-5453.
26. Weyer C, Walford R, Harper I, et al. Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment. Am J Clin Nutr 2000; 72: 946-953.